Eupraxia Pharmaceuticals Inc. Common Stock vs. Alphabet Inc. Class C Capital Stock
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
$8.40 +12.00%
VS GOOGAlphabet Inc. Class C Capital Stock
$335.31 -1.11%
Eupraxia Pharmaceuticals Inc. Common Stock and Alphabet Inc. Class C Capital Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| EPRX | GOOG | |
|---|---|---|
| Market Cap | $555.02 million | $4.10 trillion |
| Revenue (TTM) | — | $445.87 billion |
| Net Income (TTM) | — | $244.21 billion |
GOOG leads on 1 of 1 size & scale factors.
Valuation
| EPRX | GOOG | |
|---|---|---|
| P/E Ratio | — | 16.82 |
| Price / Book | — | 6.40 |
| Price / Sales | — | 9.20 |
EPRX and GOOG split the valuation factors evenly.
Profitability
| EPRX | GOOG | |
|---|---|---|
| Net Margin | — | 54.77% |
| Return on Equity | — | 38.13% |
EPRX and GOOG split the profitability factors evenly.
Dividend
| EPRX | GOOG | |
|---|---|---|
| Dividend Yield | — | 0.26% |
| Payout Ratio | — | 4.42 |
EPRX and GOOG split the dividend factors evenly.
Risk & Sentiment
| EPRX | GOOG | |
|---|---|---|
| Short Interest | 0.01% | 0.07% |
EPRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: EPRX overview, EPRX financials, GOOG overview, GOOG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.